Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Pulford, K' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 61 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pulford, K; Morris, SW; Mason, DY
      Anaplastic lymphoma kinase proteins and malignancy

      CURRENT OPINION IN HEMATOLOGY
    2. Turturro, F; Frist, AY; Arnold, MD; Seth, P; Pulford, K
      Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the anti proliferative effect of p27(Kip1)

      ONCOGENE
    3. Tort, F; Pinyol, M; Pulford, K; Roncador, G; Hernandez, L; Nayach, I; Kluin-Nelemans, HC; Kluin, P; Touriol, C; Delsol, G; Mason, D; Campo, E
      Molecular characterization of a new ALK translocation involving moesin (MSN-ALK) in anaplastic large cell lymphoma

      LABORATORY INVESTIGATION
    4. Camilleri-Broet, S; Audouin, J; Ferme, C; Briere, J; Pulford, K; Gaulard, P; Divine, M; Macintyre, E; Delsol, G; Berger, F
      ALK is not expressed in Hodgkin disease

      BLOOD
    5. Boulland, ML; Wechsler, J; Bagot, M; Pulford, K; Kanavaros, P; Gaulard, P
      Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins

      HISTOPATHOLOGY
    6. ten Berge, RL; Oudejans, JJ; Ossenkoppele, GJ; Pulford, K; Willemze, R; Falini, B; Chott, A; Meijer, CJLM
      ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occursbefore dissemination

      JOURNAL OF CLINICAL PATHOLOGY
    7. Trinei, M; Lanfrancone, L; Campo, E; Pulford, K; Mason, DY; Pelicci, PG; Falini, B
      A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma

      CANCER RESEARCH
    8. Pulford, K; Falini, B; Banham, AH; Codrington, D; Roberton, H; Hatton, C; Mason, DY
      Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma

      BLOOD
    9. Stein, H; Foss, HD; Durkop, H; Marafioti, T; Delsol, G; Pulford, K; Pileri, S; Falini, B
      CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features

      BLOOD
    10. Touriol, C; Greenland, C; Lamant, L; Pulford, K; Bernard, F; Rousset, T; Mason, DY; Delsol, G
      Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like)

      BLOOD
    11. Lamant, L; Pulford, K; Bischof, D; Morris, SW; Mason, DY; Delsol, G; Mariame, B
      Expression of the ALK tyrosine kinase gene in neuroblastoma

      AMERICAN JOURNAL OF PATHOLOGY
    12. Banham, AH; Colonna, M; Cella, M; Micklem, KJ; Pulford, K; Willis, AC; Mason, DY
      Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily

      JOURNAL OF LEUKOCYTE BIOLOGY
    13. Pulford, K; Delsol, G; Roncador, G; Biddolph, S; Jones, M; Mason, DY
      Immunohistochemical screening for oncogenic tyrosine kinase activation

      JOURNAL OF PATHOLOGY
    14. Dukers, DF; ten Berge, RL; Oudejans, JJ; Pulford, K; Hayes, D; Misere, JFMM; Ossenkoppele, GJ; Jaspars, LH; Willemze, R; Meijer, CJLM
      A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas

      JOURNAL OF CLINICAL PATHOLOGY
    15. Pulford, K; Jones, M; Banham, AH; Haralambieva, E; Mason, DY
      Lymphocyte-specific protein 1: A specific marker of human leucocytes

      IMMUNOLOGY
    16. Hernandez, L; Pinyol, M; Hernandez, S; Bea, S; Pulford, K; Rosenwald, A; Lamant, L; Falini, B; Ott, G; Mason, DY; Delsol, G; Campo, E
      TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations

      BLOOD
    17. Falini, B; Pulford, K; Pucciarini, A; Carbone, A; De Wolf-Peeters, C; Cordell, J; Fizzotti, M; Santucci, A; Pelicci, PG; Pileri, S; Campo, E; Ott, G; Delsol, G; Mason, DY
      Lymphomas expressing ALK fusion protein(s) other than NPM-ALK

      BLOOD
    18. Rosenwald, A; Ott, G; Pulford, K; Katzenberger, T; Kuhl, J; Kalla, J; Ott, MM; Mason, DY; Muller-Hermelink, HK
      t(1;2)(q21;p23) and t(2;3)(p23;q21): Two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma

      BLOOD
    19. Lamant, L; Dastugue, N; Pulford, K; Delsol, G; Mariame, B
      A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation

      BLOOD
    20. ten Berge, RL; Dukers, DF; Oudejans, JJ; Pulford, K; Ossenkoppele, GJ; de Jong, D; Misere, JFMM; Meijer, CJLM
      Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma

      BLOOD
    21. Jones, D; Fletcher, CDM; Pulford, K; Shahsafaei, A; Dorfman, DM
      The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma

      BLOOD
    22. Pulford, K; Falini, B; Cordell, J; Rosenwald, A; Ott, G; Muller-Hermelink, HK; MacLennan, KA; Lamant, L; Carbone, A; Campo, E; Mason, DY
      Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma

      AMERICAN JOURNAL OF PATHOLOGY
    23. GASCOYNE RD; WU CD; CHHANABHAI M; MORRIS SW; PULFORD K; MASON D; GREINER TC; CONNORS JM; VOSE JM; COLDMAN A; WEISENBURGER DD
      PROGNOSTIC-SIGNIFICANCE OF ALK ONCOGENE EXPRESSION IN ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL)

      Modern pathology
    24. VERGIER B; BEYLOTBARRY M; PULFORD K; MICHEL P; BOSQ J; DEMURET A; BEYLOT C; DELAUNAY MM; AVRIL MF; DALAC S; BODEMER C; JOLY P; GROPPI A; DEMASCAREL A; BAGOT M; MASON DY; WECHSLER J; MERLIO JP
      STATISTICAL EVALUATION OF DIAGNOSTIC AND PROGNOSTIC FEATURES OF CD30-A CLINICOPATHOLOGICAL STUDY OF 65 CASES( CUTANEOUS LYMPHOPROLIFERATIVE DISORDERS )

      The American journal of surgical pathology
    25. PILOZZI E; PULFORD K; JONES M; MULLERHERMELINK HK; FALINI B; RALFKIAER E; PILERI S; PEZZELLA F; DEWOLFPEETERS C; ARBER D; STEIN H; MASON D; GATTER K
      COEXPRESSION OF CD79A (JCB117) AND CD3 BY LYMPHOBLASTIC LYMPHOMA

      Journal of pathology
    26. TENBERGE RL; OUDEJANS JJ; PULFORD K; WILLEMZE R; MASON DY; MEIJER CJLM
      NPM-ALK EXPRESSION AS A DIAGNOSTIC MARKER IN CUTANEOUS CD30 POSITIVE T-CELL LYMPHOPROLIFERATIVE DISORDERS

      Journal of investigative dermatology
    27. DELABESSE E; BERNARD M; MEYER V; SMIT L; PULFORD K; CAYUELA JM; RITZ J; BOURQUELOT P; STROMINGER JL; VALENSI F; MACINTYRE EA
      TAL1 EXPRESSION DOES NOT OCCUR IN THE MAJORITY OF T-ALL BLASTS

      British Journal of Haematology
    28. BENHARROCH D; MEGUERIANBEDOYAN Z; LAMANT L; AMIN C; BRUGIERES L; TERRIERLACOMBE MJ; HARALAMBIEVA E; PULFORD K; PILERI S; MORRIS SW; MASON DY; DELSOL G
      ALK-POSITIVE LYMPHOMA - A SINGLE DISEASE WITH A BROAD-SPECTRUM OF MORPHOLOGY

      Blood
    29. BEYLOTBARRY M; GROPPI A; VERGIER B; PULFORD K; MERLIO JP
      CHARACTERIZATION OF T(2-5) RECIPROCAL TRANSCRIPTS AND GENOMIC BREAKPOINTS IN CD30(+) CUTANEOUS LYMPHOPROLIFERATIONS

      Blood
    30. FALINI B; BIGERNA B; FIZZOTTI M; PULFORD K; PILERI SA; DELSOL G; CARBONE A; PAULLI M; MAGRINI U; MENESTRINA F; GIARDINI R; PILOTTI S; MEZZELANI A; UGOLINI B; BILLI M; PUCCIARINI A; PACINI R; PELICCI PG; FLENGHI L
      ALK EXPRESSION DEFINES A DISTINCT GROUP OF T NULL LYMPHOMAS (ALK LYMPHOMAS) WITH A WIDE MORPHOLOGICAL SPECTRUM/

      The American journal of pathology
    31. SU LD; SCHNITZER B; ROSS CW; VASEF M; MORI S; SHIOTA M; MASON DY; PULFORD K; HEADINGTON JT; SINGLETON TP
      THE T(2-5)-ASSOCIATED P80 NPM ALK FUSION PROTEIN IN NODAL AND CUTANEOUS CD30+ LYMPHOPROLIFERATIVE DISORDERS/

      Journal of cutaneous pathology
    32. BISCHOF D; PULFORD K; MASON DY; MORRIS SW
      ROLE OF THE NUCLEOPHOSMIN (NPM) PORTION OF THE NON-HODGKINS LYMPHOMA-ASSOCIATED NPM-ANAPLASTIC LYMPHOMA KINASE FUSION PROTEIN IN ONCOGENESIS

      Molecular and cellular biology
    33. MEGUERIANBEDOYAN Z; LAMANT L; HOPFNER C; PULFORD K; CHITTAL S; DELSOL G
      ANAPLASTIC LARGE-CELL LYMPHOMA OF MATERNAL ORIGIN INVOLVING THE PLACENTA - CASE-REPORT AND LITERATURE SURVEY

      The American journal of surgical pathology
    34. AUER I; PULFORD K; MASON DY; STROUD D; CONNORS JM; GASCOYNE RD
      PROGNOSTIC-SIGNIFICANCE OF P80 ALK1 EXPRESSION IN DIFFUSE LARGE-CELL LYMPHOMAS(DLCL)/

      Laboratory investigation
    35. PITTALUGA S; PULFORD K; WLODARSKA I; MASON DY; VANDENBERGHE H; DEWOLFPEETERS C; LEUVEN KU
      ALK-1 ANTIBODY STAINING PATTERN IN ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL) AND ALCL-HODGKINS LIKE

      Laboratory investigation
    36. WOOD KM; PARR A; JACK F; PULFORD K; LESSELLS AM; KRAJEWSKI AS; LEVISON DA; GOODLAD J; THOMPSON WD; LEE FD; HOME CHW; ANGUS B
      EXPRESSION OF THE P80 NPM ALK FUSION PROTEIN IN ANAPLASTIC LYMPHOMA/

      Journal of pathology
    37. BEYLOTBARRY M; VERGIER B; PULFORD K; BOSQ MJ; DEMURET A; BEYLOT C; DELAUNAY MM; AVRIL MF; DALAC S; BODEMER C; JOLY P; BAGOT M; DEMASCAREL A; MANSON DY; WECHSLER J; MERLIO JP
      DIFFERENT PROGNOSIS BETWEEN CUTANEOUS AND SYSTEMIC CD30+ LYMPHOPROLIFERATIVE DISORDERS IS NOT SUPPORTED BY BIOLOGICAL DATA

      Journal of investigative dermatology
    38. BANHAM AH; TURLEY H; PULFORD K; GATTER K; MASON DY
      THE PLASMA-CELL ASSOCIATED ANTIGEN DETECTABLE BY ANTIBODY VS38 IS THEP63 ROUGH ENDOPLASMIC-RETICULUM PROTEIN

      Journal of Clinical Pathology
    39. KUEFER MU; LOOK AT; PULFORD K; BEHM FG; PATTENGALE PK; MASON DY; MORRIS SW
      RETROVIRUS-MEDIATED GENE-TRANSFER OF NPM-ALK CAUSES LYMPHOID MALIGNANCY IN MICE

      Blood
    40. DELSOL G; LAMANT L; MARIAME B; PULFORD K; DASTUGUE N; BROUSSET P; RIGALHUGUET F; ALSAATI T; CERRETTI DP; MORRIS SW; MASON DY
      A NEW SUBTYPE OF LARGE B-CELL LYMPHOMA EXPRESSING THE ALK KINASE AND LACKING THE 2-5-TRANSLOCATION

      Blood
    41. PULFORD K; LAMANT L; MORRIS SW; BUTLER LH; WOOD KM; STROUD D; DELSOL G; MASON DY
      DETECTION OF ANAPLASTIC LYMPHOMA KINASE (ALK) AND NUCLEOLAR PROTEIN NUCLEOPHOSMIN (NPM)-ALK PROTEINS IN NORMAL AND NEOPLASTIC-CELLS WITH THE MONOCLONAL-ANTIBODY ALK1

      Blood
    42. PITTALUGA S; WLODARSKA I; PULFORD K; CAMPO E; MORRIS SW; VANDENBERGHE H; DEWOLFPEETERS C
      THE MONOCLONAL-ANTIBODY ALK1 IDENTIFIES A DISTINCT MORPHOLOGICAL SUBTYPE OF ANAPLASTIC LARGE-CELL LYMPHOMA ASSOCIATED WITH 2P23 ALK REARRANGEMENTS/

      The American journal of pathology
    43. PILERI SA; PULFORD K; MORI S; MASON DY; SABATTINI E; RONCADOR G; PICCIOLI M; CECCARELLI C; PICCALUGA PP; SANTINI D; LEONE O; STEIN H; FALINI B
      FREQUENT EXPRESSION OF THE NPM-ALK CHIMERIC FUSION PROTEIN IN ANAPLASTIC LARGE-CELL LYMPHOMA, LYMPHO-HISTIOCYTIC TYPE

      The American journal of pathology
    44. CHETTY R; PULFORD K; JONES M; MATHIEUMAHUL D; CLOSE P; HUSSEIN S; PALLESEN G; RALFKIAER E; STEIN H; GATTER K; MASON D
      AN IMMUNOHISTOCHEMICAL STUDY OF TAL-1 PROTEIN EXPRESSION IN LEUKEMIASAND LYMPHOMAS WITH A NOVEL MONOCLONAL-ANTIBODY, 2TL-242

      Journal of pathology
    45. DELABESSE E; BERNARD M; MEYER V; SMIT L; PULFORD K; LANDMANPARKER J; STROMINGER JL; VARET B; VALENSI F; MACINTYRE E
      TAL-1 EXPRESSION DOES NOT OCCUR IN THE MAJORITY OF T-ALL BLASTS

      Blood
    46. BOURQUELOT PM; MEYER V; DELABESSE E; BERNARD M; PULFORD K; GARAND R; IMBERT M; VALENSI F; VAREL B; FLANDRIN G; MACINTYRE EA
      EXPRESSION OF THE TAL1 PROTEIN IN AML - CORRELATION WITH MORPHOLOGY, IMMUNOPHENOTYPE, MOLECULAR-GENETICS AND PROGNOSIS

      Blood
    47. PULFORD K; JONES M; STROUD D; MASON DY
      IMMUNOCYTOCHEMICAL DISTRIBUTION OF THE CDW75 ANTIGEN

      Tissue antigens
    48. TURLEY H; BANHAM A; JONES M; PULFORD K; GATTER K; MASON D
      2 ANTI-PLASMA CELL ANTIBODIES RECOGNIZING A MOLECULE ASSOCIATED WITH ROUGH ENDOPLASMIC-RETICULUM

      Tissue antigens
    49. PULFORD K; JONES M; STROUD D; MASON DY
      FLOW CYTOMETRIC CHARACTERIZATION OF THE CYTOPLASMIC BLIND B-CELL PANEL OF REAGENTS

      Tissue antigens
    50. CHETTY R; CERRONI L; PULFORD K; GIATROMANOLAKI A; BIDDOLPH S; KAKLAMANIS L; GATTER K
      TAL1 GENE DELETIONS AND TAL1 PROTEIN EXPRESSION IN SPORADIC MELANOMA

      Melanoma research
    51. TOOZE JA; SASO R; MARSH JCW; PAPADOPOULOS A; PULFORD K; GORDONSMITH EC
      THE NOVEL MONOCLONAL-ANTIBODY BY114 HELPS DETECT THE EARLY EMERGENCE OF A PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA CLONE IN APLASTIC-ANEMIA

      Experimental hematology
    52. CHETTY R; PULFORD K; JONES M; MATHIEUMAHUL D; CLOSE P; HUSSEIN S; PALLESEN G; RALFKIAER E; STEIN H; GATTER K; MASON D
      SCL TAL-1 EXPRESSION IN T-ACUTE LYMPHOBLASTIC-LEUKEMIA - AN IMMUNOHISTOCHEMICAL AND GENOTYPIC STUDY/

      Human pathology
    53. MASON DY; CORDELL JL; BROWN MH; BORST J; JONES M; PULFORD K; JAFFE E; RALFKIAER E; DALLENBACH F; STEIN H; PILERI S; GATTER KC
      CD79A - A NOVEL MARKER FOR B-CELL NEOPLASMS IN ROUTINELY PROCESSED TISSUE SAMPLES

      Blood
    54. PULFORD K; LECOINTE N; LEROYVIARD K; JONES M; MATHIEUMAHUL D; MASON DY
      EXPRESSION OF TAL-1 PROTEINS IN HUMAN TISSUES

      Blood
    55. BERNARD M; SMIT L; MACINTYRE E; MATTHIEUMAHUL D; PULFORD K
      NUCLEAR-LOCALIZATION OF THE SCL TAL1 BASIC HELIX-LOOP-HELIX PROTEIN IS NOT DEPENDENT ON THE PRESENCE OF THE BASIC DOMAIN/

      Blood
    56. PEZZELLA F; MICKLEM K; TURLEY H; PULFORD K; JONES M; KOCIALKOWSKI S; DELIA D; AIELLO A; BICKNELL R; SMITH K; HARRIS AL; GATTER KC; MASON DY
      ANTIBODY FOR DETECTING P53 PROTEIN BY IMMUNOHISTOCHEMISTRY IN NORMAL-TISSUES

      Journal of Clinical Pathology
    57. CORDELL JL; PULFORD K; TURLEY H; JONES M; MICKLEM K; DOUSSIS IA; TYLER X; MAYNE K; GATTER KC; MASON DY
      CELLULAR-DISTRIBUTION OF HUMAN-LEUKOCYTE ADHESION MOLECULE ICAM-3

      Journal of Clinical Pathology
    58. PULFORD K; MICKLEM KJ; JONES M; PEZZELLA F; MAYNE KM; MORRISON H; THOMAS J; FALINI B; NORTON A; MASON DY
      A NOVEL INTERNAL ANTIGEN WHICH DISTINGUISHES GERMINAL CENTER CELLS FROM OTHER B-CELL TYPES

      Immunology
    59. BJERKE K; HALSTENSEN TS; JAHNSEN F; PULFORD K; BRANDTZAEG P
      DISTRIBUTION OF MACROPHAGES AND GRANULOCYTES EXPRESSING L1 PROTEIN (CALPROTECTIN) IN HUMAN PEYERS-PATCHES COMPARED WITH NORMAL ILEAL LAMINAPROPRIA AND MESENTERIC LYMPH-NODES

      Gut
    60. WEBSTER R; PULFORD K; JONES M; MICKLEM K; DEWAELE M; MAYNE K; TSE A; MASON DY
      ZB51 - A MONOCLONAL-ANTIBODY REACTIVE WITH HUMAN PLASMA-CELLS

      British Journal of Haematology
    61. DOUSSISANAGNOSTOPOULOU I; KAKLAMANIS L; CORDELL J; JONES M; TURLEY H; PULFORD K; SIMMONS D; MASON D; GATTER K
      ICAM-3 EXPRESSION ON ENDOTHELIUM IN LYMPHOID MALIGNANCY

      The American journal of pathology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 10:02:51